Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. ✅
Acta paediatrica (Oslo, Norway : 1992). Supplement (Acta Paediatr Suppl ) Vol: 94 Issue 449 Pages: 31-3 Pub: 2005 Oct Epub: Authors Knol J , Boehm G , Lidestri M , Negretti F , Jelinek J , Agosti M , Stahl B , Marini A , Mosca F , |
|
|
Wheat-derived arabinoxylan oligosaccharides with bifidogenic properties abolishes metabolic disorders induced by western diet in mice. ✅
Go to Publication ✅
Nutrition & diabetes (Nutr Diabetes ) Vol: 8 Issue 1 Pages: 15 Pub: 2018 Mar 7 Epub: 2018 Mar 7 Authors Neyrinck AM , Hiel S , Bouzin C , Campayo VG , Cani PD , Bindels LB , Delzenne NM , |
|
|
An ATP Binding Cassette Transporter Mediates the Uptake of a-(1,6)-Linked Dietary Oligosaccharides in Bifidobacterium and Correlates with Competitive Growth on These Substrates. ✅
Go to Publication ✅
The Journal of biological chemistry (J Biol Chem ) Vol: 291 Issue 38 Pages: 20220-31 Pub: 2016 Sep 16 Epub: 2016 Aug 8 Authors Ejby M , Fredslund F , Andersen JM , Vujicic Žagar A , Henriksen JR , Andersen TL , Svensson B , Slotboom DJ , Abou Hachem M , |
|
|
Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 48 Issue 5 Pages: 1644-52 Pub: 2000 May Epub: Authors Van Laere KM , Hartemink R , Bosveld M , Schols HA , Voragen AG , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.